Literature DB >> 28173962

Prevalence of healthcare-associated infections in Polish adult intensive care units: summary data from the ECDC European Point Prevalence Survey of Hospital-associated Infections and Antimicrobial Use in Poland 2012-2014.

A Deptuła1, E Trejnowska2, G Dubiel3, M Żukowski4, A Misiewska-Kaczur5, T Ozorowski6, W Hryniewicz7.   

Abstract

BACKGROUND: Infection is a major cause of morbidity and mortality in intensive care units (ICUs) worldwide. Local epidemiological studies need to be conducted to set the priorities for surveillance and prevention programmes. AIM: To investigate the epidemiology of hospital-acquired infections (HAIs) among patients admitted to Polish adult ICUs over a three-year period.
METHODS: Data were collected according to the European Centre for Disease Prevention and Control (ECDC) European Union Point Prevalence Survey of Healthcare-associated Infections and Antimicrobial Use in European Acute Care Hospitals (EU-PPS HAI & AU) protocol for 39,318 patients within 160 acute care hospitals. From this initial database, data for adult ICU patients (N=945) were filtered for further analyses.
FINDINGS: HAIs were present in 370 patients (39%) and 430 HAI episodes were recorded. The most common HAIs were respiratory tract infections (45%), usually caused by Enterobacteriaceae and Gram-negative non-fermenters. The majority (87%) of these infections were likely to be device associated. Out of 61 cases of bloodstream infection, 51% were catheter associated. These bloodstream infections were mainly caused by coagulase-negative staphylococci. Among 57 cases of surgical site infection, 42% were classified as organ/space, 33% were classified as deep incisional, and 25% were classified as superficial. The predominant micro-organisms were Enterobacteriaceae and Staphylococcus aureus. Out of 50 cases of urinary tract infection, 96% were device associated.
CONCLUSIONS: The prevalence of HAI among Polish adult ICU patients is higher than described in similar studies, but may be partially affected by methodological differences. The proportion of device-associated infections was very high, so there is an urgent need to introduce countrywide, targeted surveillance and prevention programmes.
Copyright © 2017 The Healthcare Infection Society. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  ECDC point prevalence survey; Epidemiology; Healthcare-associated infections; ICU

Mesh:

Year:  2017        PMID: 28173962     DOI: 10.1016/j.jhin.2016.12.020

Source DB:  PubMed          Journal:  J Hosp Infect        ISSN: 0195-6701            Impact factor:   3.926


  5 in total

1.  Point prevalence surveys of health-care-associated infections: a systematic review.

Authors:  Zikria Saleem; Brian Godman; Mohamed Azmi Hassali; Furqan Khurshid Hashmi; Faiza Azhar; Inayat Ur Rehman
Journal:  Pathog Glob Health       Date:  2019-06-19       Impact factor: 2.894

2.  Hand hygiene compliance in intensive care units: An observational study.

Authors:  Magdalena Hoffmann; Gerald Sendlhofer; Veronika Gombotz; Gudrun Pregartner; Renate Zierler; Christine Schwarz; Christa Tax; Gernot Brunner
Journal:  Int J Nurs Pract       Date:  2019-10-31       Impact factor: 2.226

3.  Hospital-acquired infections caused by enterococci: a systematic review and meta-analysis, WHO European Region, 1 January 2010 to 4 February 2020.

Authors:  Simon Brinkwirth; Olaniyi Ayobami; Tim Eckmanns; Robby Markwart
Journal:  Euro Surveill       Date:  2021-11

4.  Hospital acquired infections in a private paediatric hospital in Kenya: a retrospective cross-sectional study.

Authors:  Rohini Kalagouda Patil; Beatrice Kabera; Charles Kiilu Muia; Boni Maxime Ale
Journal:  Pan Afr Med J       Date:  2022-01-11

5.  Surveillance of Antibiotic Prescribing in Intensive Care Units in Poland.

Authors:  Ewa Trejnowska; Aleksander Deptuła; Magda Tarczyńska-Słomian; Piotr Knapik; Miłosz Jankowski; Agnieszka Misiewska-Kaczur; Barbara Tamowicz; Jakub Śmiechowicz; Remigiusz Antończyk; Paul Armatowicz; Wiktor Sułkowski; Grażyna Durek
Journal:  Can J Infect Dis Med Microbiol       Date:  2018-08-28       Impact factor: 2.471

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.